Robert Rifkin, MD, FACP, Attending Physician, Department of Cellular Therapy, Presbyterian/St. Luke’s Medical Center, offers opinion on the most promising studies in multiple myeloma (MM) presented at ASH 2019.
Advertisement
By Editor
Robert Rifkin, MD, FACP, Attending Physician, Department of Cellular Therapy, Presbyterian/St. Luke’s Medical Center, offers opinion on the most promising studies in multiple myeloma (MM) presented at ASH 2019.